The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis. Qiu L, Xu Y, Xu H, Yu B, et al. BMC Cancer 2022;22:681.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qiu L, Xu Y, Xu H, Yu B, et al. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis. BMC Cancer 2022;22:681.
PMID: 35729596